Literature DB >> 27383869

Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature.

Dorotea Ninković, Vladimir Sarnavka, Anica Bašnec, Mario Ćuk, Danijela Petković Ramadža, Ksenija Fumić, Vesna Kušec, René Santer, Ivo Barić.   

Abstract

Hyperinsulinism-hyperammonemia (HI/HA) syndrome is a rare autosomal dominant disease characterized by recurrent hypoglycemia and persistent mild elevation of plasma ammonia. HI/HA syndrome is one of the more common forms of congenital hyperinsulinism (CHI), caused by activating mutations within the GLUD1 gene that encodes the mitochondrial enzyme glutamate dehydrogenase (GDH). We report here on monozygotic twin girls presented with fasting- and protein-induced hypoglycemia and mild persistent hyperammonemia. Genetic analysis revealed that both girls were heterozygous for a novel missense mutation within exon 11 [c.1499A>T, p.(R443W)] of the GLUD1 gene. Despite early treatment with diazoxide and a low protein diet, they both developed non-hypoglycemic seizures in early childhood followed by cognitive impairment. In addition to their clinical course, a review of the literature on HI/HA syndrome is provided.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27383869     DOI: 10.1515/jpem-2016-0086

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

1.  Clinical and Molecular Spectrum of Glutamate Dehydrogenase Gene Defects in 26 Chinese Congenital Hyperinsulinemia Patients.

Authors:  Chang Su; Xue-Jun Liang; Wen-Jing Li; Di Wu; Min Liu; Bing-Yan Cao; Jia-Jia Chen; Miao Qin; Xi Meng; Chun-Xiu Gong
Journal:  J Diabetes Res       Date:  2018-09-16       Impact factor: 4.011

Review 2.  Treatable inherited metabolic epilepsies.

Authors:  Khalid Hundallah; Brahim Tabarki
Journal:  Neurosciences (Riyadh)       Date:  2021-07       Impact factor: 0.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.